Navigation Links
Next Stage Solutions Announces Three New Financial Services For Emerging Business
Date:6/10/2009

Next Stage Solutions, Inc. has expanded its financial services offerings to further meet the needs of emerging businesses. Specifically, Next Stage Solutions (NSS) has launched three new services: First, CFO on Demand - NSS partners with their clients acting as an outsourced CFO on an as-needed basis. Second, Strategic Finance - the Next Stage Solutions team equips its clients with multiple game plans; a blue print for every contingency. And third, Collective Knowledge - NSS offers years of experience implementing new financial strategies from a team who possesses complementary skill sets with varied backgrounds.

Lexington, MA (PRWEB) June 10, 2009 -- Next Stage Solutions, Inc. has expanded its financial services offerings to further meet the needs of emerging businesses. Specifically, Next Stage Solutions (NSS) has launched three new services: First, CFO on Demand - NSS partners with their clients acting as an outsourced CFO on an as-needed basis. Second, Strategic Finance - the Next Stage Solutions team equips its clients with multiple game plans; a blue print for every contingency. And third, Collective Knowledge - NSS offers years of experience implementing new financial strategies from a team who possesses complementary skill sets with varied backgrounds.

Specifically, Next Stage Solutions (NSS) has launched three new services:

1. CFO on Demand. In emerging businesses, CFOs are often hired too early or too late; and all too frequently, emerging businesses hire a CFO who is not the right fit. The cost of these mistakes is staggering, both in dollars and efficiency: the average rate of CFO turnover at small and midsized companies is merely 20 months; the cost of screening and hiring two CFOs in a 20 month span can reach as high as $800,000, not including the disruption to the company as it transitions between the two CFOs. NSS confronts this problem by acting as an ou
'/>"/>

Source: PRWeb
Copyright©2009 Vocus, Inc.
All rights reserved  

Page: 1 2 3

Related biology technology :

1. Sunesis Pharmaceuticals Announces Reorganization to Focus Resources and Build Value in Clinical-Stage Programs
2. NxStage Medical to Present at the Thomas Weisel Partners Healthcare Conference on September 5, 2007
3. NxStage Medical Provides Update on Medisystems Acquisition
4. Kiwa Bio-Tech Completes 1st Stage of Shandong Factory Upgrading
5. HUYA Bioscience International Licenses Clinical Stage Anti-Arrhythmic Compound from the Shanghai Institute of Materia Medica
6. OPKO Health Acquires Rights to Clinical Stage Compound for Dry Eye
7. NxStage(R) Medical to Report Third Quarter 2007 Financial Results on Friday, November 2nd
8. Arbios Announces SEPET(TM) Manufacturing Agreement With NxStage Medical
9. Micromet Data Presented at the International AACR-NCI-EORTC Conference Support the Development of Adecatumumab (MT201) in Earlier Stage Cancer Disease Settings
10. Genzyme Launches Cholestagel(R) in Europe
11. National Stem Cell Holding in Final Stage Negotiations for Exclusive Licensing of its Recently Discovered Biomaterial for Anti-Aging Applications

Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Next Stage Solutions Announces Three New Financial Services For Emerging Business
Next Stage Solutions Announces Three New Financial Services For Emerging Business
(Date:12/2/2009)... , , CAMBRIDGE, Mass., Dec. 2 /PRNe...gether the leaders in technology development and p... and MEMS, announced the December 11th deadline fo... ,, Now in its 14th year, TechConnect World, in...Institute (NSTI), and the Clean Technology and Sus...
(Date:12/2/2009)... , , RESTON, Va., Dec. 2 /PRNewswi...d Dairy" or the "Company") (OTC Bulletin Board: EM...and children,s formula, milk powder and,soybean pr...will be featured,in the Spring issue of US Food &a...eadership of over 250,000 executives in the food a...
(Date:12/2/2009)... , , SHANGHAI, Dec. 2 /PRNewswire-...times; markets are in turmoil and uncertainty is p...t that the pharma industry has been,relatively imm...n,t take a,vacation. , During the midst o...l,giant Johnson & Johnson inaugurated an R&...
(Date:12/1/2009)... , Dr. Kerry Solomon anno...ns and has launched his redesigned website at www...al Consulting Group. Dr. Solomon is a proven LASI...as been professionally recognized for his substant...urgery. He is a member of Trusted LASIK Surgeons,...
Breaking Biology Technology:Deadline Approaching for Largest Commercialization Event for Nanotech & Clean Technologies 2Deadline Approaching for Largest Commercialization Event for Nanotech & Clean Technologies 3Emerald Dairy To Be Featured in Spring Issue of US Food and Drink Executive 2Pharma and Biotech Leaders to Converge in China at Asia Pharma R&D Leaders 2010 Summit 2Pharma and Biotech Leaders to Converge in China at Asia Pharma R&D Leaders 2010 Summit 3Charleston LASIK and Cataract Expert Dr. Kerry Solomon Opens New Practice and Launches DrKerrySolomon.com 2Charleston LASIK and Cataract Expert Dr. Kerry Solomon Opens New Practice and Launches DrKerrySolomon.com 3Charleston LASIK and Cataract Expert Dr. Kerry Solomon Opens New Practice and Launches DrKerrySolomon.com 4Charleston LASIK and Cataract Expert Dr. Kerry Solomon Opens New Practice and Launches DrKerrySolomon.com 5Charleston LASIK and Cataract Expert Dr. Kerry Solomon Opens New Practice and Launches DrKerrySolomon.com 6
...ntrols Inc. (OTCBB: FOUR.OB) today announced it ha...r. Philip Hayden as its Vice President, Security A... NEW YORK (Business Wire EON) August 18... distinguished career with the Federal Bureau of I...volved in many aspects of law enforcement and secu...
...on in Upfront Fees and Milestones -, DALLAS, Aug....ard: ACCP) and Milestone Biosciences, LLC ("Milest...license agreement under which,Milestone will marke...ited,States and Canada. Milestone is a company rec...sentatives of companies with an established,commer...
... China, Aug. 18 /PRNewswire-FirstCall/,-- MicuRx P...utical company,developing next-generation antibiot...ts first preclinical development candidate. MRX-I ...resistant gram-positive,bacteria, including methic...ltaneously, the company expanded its operations in...
Other Biology Technology: 4C Controls Announces the Appointment of Dr. Philip Hayden as Vice President, Security Assessment & Threat Analysis 2 4C Controls Announces the Appointment of Dr. Philip Hayden as Vice President, Security Assessment & Threat Analysis 3 4C Controls Announces the Appointment of Dr. Philip Hayden as Vice President, Security Assessment & Threat Analysis 4Access Pharmaceuticals Licenses MuGard to Milestone Biosciences, LLC for North America 2Access Pharmaceuticals Licenses MuGard to Milestone Biosciences, LLC for North America 3MicuRx Pharmaceuticals Selects Next-Generation Antibiotic Candidate Targeting MRSA and Expands Operation in China 2
(Date:12/4/2009)...g the total gene activity in organs relevant for c...edish medical university Karolinska Institutet hav...or the recruitment of white blood cells into the a...be published in the open-access journal PLoS Gene...te blood cells in the development of atheroscleros...
(Date:12/4/2009)...se is available in German . , A new study of ...ld help to understand the positive effect of dieta...e from different organisms (fruit flies and mice) ...evity, but with a potential negative side effect o...produces less frequently with a reduced litter siz...
(Date:12/3/2009)... WALL, N.J., Dec. 3 BIO-..., a leader in wireless public safety and finger-ba...that a majority of its shareholders at a Special S... the company,s Law Enforcement Division to Interac...% were cast in favor and 1.2% were opposed. ,, ...
Breaking Biology News(10 mins):Scientists discover gene module underlying atherosclerosis development 2How nutrition affects healthy aging 2BIO-key(R) Shareholders Overwhelmingly Approve Sale of Law Enforcement Division 2BIO-key(R) Shareholders Overwhelmingly Approve Sale of Law Enforcement Division 3Vermillion Announces Return of Eric Fung M D Ph D 14338 1Vermillion Announces Return of Eric Fung M D Ph D 14338 2Vermillion Announces Return of Eric Fung M D Ph D 14338 3Cantel Medical Corp To Hold Conference Call To Discuss Fourth Quarter and Fiscal 2009 Results 5196 1Cantel Medical Corp To Hold Conference Call To Discuss Fourth Quarter and Fiscal 2009 Results 5196 2ISTA Pharmaceuticals Announces Conference Call and Webcast of Third Quarter 2009 Financial Results 5193 1
...elease is available in French . , Montreal, May...leted a massive survey of the network of protein c...s of life. In the online edition of the journal Sc...escribe protein complexes and networks of complexe...in the normal mechanisms by which cells divide and...
...helle, NY, May 13, 2008Gene therapy to replace the...e disease that is fatal by age 8-12 years, was abl...line in treated children, according to a paper pub... (Vol. 19 No. 5) of Human Gene Therapy, a peer-rev...The paper is available free online at www.liebertp...
... (May 13, 2008) Lunar dust could be more than a ...on. Their good health may depend on the amount of ...epare for a return to the moon, researchers with t...SBRI) are evaluating how dust deposits in the lung... risk of long-term exposure to the particles. The ...
Other Biology News:Researchers discover architecture for fundamental processes of life 2Gene therapy slows progression of fatal neurodegenerative disease in children 2Astronaut health on moon may depend on good dusting 2
Mouse Anti-Lamin B1, B2 Monoclonal Antibody, Unconjugated, Clone X223 from Abcam
Rabbit Anti-TAB1 Polyclonal Antibody, Unconjugated from Abcam
Rabbit Anti-FANCE Polyclonal Antibody, Unconjugated from Abcam
Rabbit Anti-Human FANCG Polyclonal Antibody, Unconjugated from Abcam
Biology Products: